Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
Abstract Mesenchymal stem cells (MSCs) have attracted considerable interest as a promising approach for cancer treatment due to their ability to undergo tumor-trophic migration. MSCs possess the unique ability to selectively migrate to tumors, making them an excellent candidate for targeted delivery...
Main Authors: | Hadi Esmaeili Gouvarchin Ghaleh, Gazal Vakilzadeh, Ali Zahiri, Mahdieh Farzanehpour |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-023-01232-y |
Similar Items
-
Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01) -
Current status and research progress of oncolytic virus
by: Yingyu Chen, et al.
Published: (2024-12-01) -
Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs
by: Guillaume St-Cyr, et al.
Published: (2023-01-01) -
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
by: Anne Everts, et al.
Published: (2020-11-01) -
Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
by: Richard Kolade Omole, et al.
Published: (2022-12-01)